Trupanion, Inc. (NASDAQ:TRUP) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Consensus "Hold": Six analysts average a $42.25 12‑month price target for TRUP (1 sell, 3 hold, 2 buy), and several firms have recently cut targets or downgraded the stock.
• Q1 beat but margin concerns: Trupanion posted $0.11 EPS vs. $0.07 expected and $384.05M revenue (+12.3% YoY), yet profitability remains thin (net margin ~1.7%, modest ROE) and EPS guidance was not clearly specified despite revenue guidance roughly in line with estimates.
• Mixed investor flows: notable institutional accumulation (e.g., Millennium, Goldman, Two Sigma) could support the stock, while insiders sold about 21,503 shares in the past 90 days; TRUP trades near $24 with a one‑year range of $23.80–$57.88 and a market cap around $1.06B.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) has been given an average recommendation of "Hold" by the six ratings firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $42.25.

Several research analysts have recently weighed in on the stock. Bank of America decreased their target price on shares of Trupanion from $63.00 to $59.00 and set a "buy" rating for the company in a research note on Tuesday, April 14th. Stifel Nicolaus dropped their price target on shares of Trupanion from $35.00 to $31.00 and set a "hold" rating on the stock in a research note on Tuesday, March 31st. Zacks Research lowered shares of Trupanion from a "strong-buy" rating to a "hold" rating in a report on Friday, February 13th. Weiss Ratings downgraded Trupanion from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Wednesday, March 4th. Finally, Cantor Fitzgerald dropped their target price on Trupanion from $42.00 to $34.00 and set a "neutral" rating on the stock in a research report on Thursday, April 9th.

Key Stories Impacting Trupanion

Here are the key news stories impacting Trupanion this week:

• Positive Sentiment: Q1 earnings and revenue beat expectations: TRUP posted $0.11 EPS vs. $0.07 consensus and revenue of $384.05M (vs. ~$379.8M est.), with revenue +12.3% YoY — a clear growth print that supports the rally. Zacks: TRUP Q1 beat
• Positive Sentiment: Secular demand thesis reiterated by management: CEO commentary highlighted widening gap in veterinary costs and pet-owners’ planning needs — a tailwind for insurance adoption and pricing leverage over time. Press release
• Positive Sentiment: Institutional accumulation noted in filings and newsfeeds (Millennium, Goldman, Two Sigma increases), which can provide support to the share price. MarketBeat: institutional flows
• Neutral Sentiment: Company issued Q2 revenue guidance of ~$386M–$392M (consensus ~389.1M) and FY revenue around $1.6B, but EPS guidance was not clearly specified in releases — the revenue ranges are roughly in line with Street estimates, leaving room for interpretation on near-term profitability. (Company guidance entry)
• Neutral Sentiment: Management held an earnings call/transcript is available for detail on margin drivers and cadence; investors will watch commentary on loss ratios, customer acquisition efficiency and vet-direct pay adoption for signals on margin recovery. Earnings call transcript
• Negative Sentiment: Analysts and coverage show rising concern on growth-efficiency tradeoffs and some price-target cuts; media pieces flagged mounting efficiency questions, which could pressure sentiment if management cannot show margin improvement. Investing.com: efficiency concerns
• Negative Sentiment: Profitability remains thin: reported net margin ~1.35% and ROE ~5.4% despite revenue growth — investors focused on whether scale will convert to meaningful margin expansion. MarketBeat: Q1 metrics
• Negative Sentiment: Small insider sale: COO sold 431 shares (minor), which is typically not material but will be noted by some investors. InsiderTrades: COO sale

Insider Buying and Selling at Trupanion

In other Trupanion news, CRO Emily Dreyer sold 7,792 shares of Trupanion stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total transaction of $219,344.80. Following the sale, the executive directly owned 35,627 shares in the company, valued at $1,002,900.05. The trade was a 17.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 2,837 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $26.46, for a total value of $75,067.02. The SEC filing for this sale provides additional information. Insiders sold a total of 21,503 shares of company stock worth $578,537 in the last 90 days. 5.42% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TRUP. Federated Hermes Inc. bought a new stake in shares of Trupanion in the 3rd quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Trupanion during the third quarter worth about $39,000. Kemnay Advisory Services Inc. acquired a new position in Trupanion in the fourth quarter worth about $64,000. Kelleher Financial Advisors acquired a new position in Trupanion in the third quarter worth about $74,000. Finally, PNC Financial Services Group Inc. increased its holdings in Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider's stock valued at $116,000 after buying an additional 478 shares during the last quarter.

Trupanion Stock Performance

Shares of NASDAQ:TRUP opened at $24.33 on Friday. The business's 50-day simple moving average is $26.31 and its 200 day simple moving average is $32.95. The company has a market cap of $1.06 billion, a P/E ratio of 54.07 and a beta of 1.50. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.69 and a current ratio of 1.69. Trupanion has a one year low of $23.80 and a one year high of $57.88.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. The company had revenue of $384.05 million during the quarter, compared to the consensus estimate of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.98%. Trupanion's revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.03) earnings per share. On average, sell-side analysts forecast that Trupanion will post 0.5 earnings per share for the current fiscal year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.